Ac-YVAD-cmk improves neurological function by inhibiting caspase-1-mediated inflammatory response in the intracerebral hemorrhage of rats
- Int Immunopharmacol. 2019 Oct;75:105771. doi: 10.1016/j.intimp.2019.105771.
- 1. Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China.
- 2. Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China; Department of Neurosurgery, Xinyang Central Hospital, Xinyang, P.R. China.
- 3. School of Life Science, Northeast Agricultural University, Harbin, P.R. China.
- 4. Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P.R. China.
- 5. Department of Pathology, First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China.
- 6. Department of Neurology, First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China.
- 7. Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China. Electronic address: [email protected].
- 8. Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, P.R. China. Electronic address: [email protected].
Objective: Intracerebral hemorrhage (ICH) is acknowledged as a serious clinical problem lacking effective treatments. And caspase-1-mediated inflammatory response happened during the progression of ICH. Therefore, we aimed to investigate the effects of Caspase-1 inhibitor Ac-YVAD-cmk on ICH.
Materials and methods: Microglia cells were isolated and activated by Thrombin for 24 h. Then the transcript and protein expressions of NLRP3 and inflammatory factors were assessed by RT-PCR and western blotting. Moreover, Ac-YVAD-cmk was injected into the ICH model. The mNSS and brain water content were tested at 24 h post-ICH. Finally, the pathological changes of microglia activation following ICH were discovered by the immunohistochemical and HE staining ways.
Results: Ac-YVAD-cmk inhibited the activation of pro-caspase-1 and decreased brain edema, in association with decreasing activated microglia and the expression of inflammation-related factors at 24 h post-ICH. Consequently, Ac-YVAD-cmk reduced the release of mature IL-1β/IL-18 in perihematoma, improved the behavioral performance, and alleviated microglia in perihematoma region in ICH rats.
Conclusions: These results indicate that Caspase-1 could amplify the plural inflammatory responses in the ICH. Administration of Ac-YVAD-cmk has the potential to be a novel therapeutic strategy for ICH.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CaspaseResearch Areas: Inflammation/Immunology